(Q40373073)

19 September 2017

title

Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study (English)

1 reference

19 September 2017

1 reference

venous thromboembolism

1 reference

Alok A Khorana

1 reference

19 September 2017

Charles W Francis

series ordinal

1 reference

19 September 2017

Eva Culakova

series ordinal

1 reference

19 September 2017

Gary H Lyman

series ordinal

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

19 September 2017

1 reference

19 September 2017

volume

104

1 reference

19 September 2017

1 reference

19 September 2017

page(s)

2822-2829

1 reference

Malignancy, thrombosis and Trousseau: the case for an eponym.

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and the angiogenesis inhibitor SU5416.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

The hypercoagulable state of malignancy: pathogenesis and current debate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Tissue factor, thrombin, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Venous thrombosis in cancer patients: insights from the FRONTLINE survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Thrombocytosis as a useful prognostic indicator in patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Poor prognosis associated with thrombocytosis in patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Pancreatic cancer and thromboembolic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Infection and inflammation and the coagulation system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

Prognosis of Cancers Associated with Venous Thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

7 January 2021

Potentiation of endothelial cell proliferation by fibrin(ogen)-bound fibroblast growth factor-2

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

7 January 2021

Pathogenesis of thrombosis in patients with malignancy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

7 January 2021

Outcomes and cost of deep venous thrombosis among patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

7 January 2021

Hemostatic Abnormalities in Malignancy, a Prospective Study of One Hundred Eight Patients: Part I. Coagulation Studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

7 January 2021

Venous thromboembolism among patients with advanced lung cancer randomized to prinomastat or placebo, plus chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

7 January 2021

Deep venous thrombosis and pulmonary artery embolism in high-grade non Hodgkin's lymphoma: incidence, causes and prognostic relevance.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

7 January 2021

Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

7 January 2021

Management of anemia in patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21496

7 January 2021

https://api.fatcat.wiki/v0/release/vtqywqjt7nexxcidt6lccj2bnm

Identifiers

1 reference

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_vtqywqjt7nexxcidt6lccj2bnm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vtqywqjt7nexxcidt6lccj2bnm

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/vtqywqjt7nexxcidt6lccj2bnm

1 reference

30 July 2022